Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
Kommende kliniske forsøg
-
NCT04434937RekrutteringBetingelser: Lymfom
-
NCT03600883RekrutteringBetingelser: ensemble ami
-
NCT04659161RekrutteringBetingelser: Schizophrenia, Skizofreni; Psykose
-
NCT04781322RekrutteringBetingelser: Alcohol Associated Liver Disease, Tung drikkeadfærd
-
NCT03514433RekrutteringBetingelser: Kræft, bryst
-
NCT04612790RekrutteringBetingelser: Bulløs Pemphigoid
-
NCT04318717RekrutteringBetingelser: Slimhinde-melanom i hoved og nakke
-
NCT04583072RekrutteringBetingelser: Prostatakræft (diagnose)
-
NCT03329092RekrutteringBetingelser: Complicated Intra-abdominal Infection, Hosptial erhvervet lungebetændelse, Ventilatorassocieret lungebetændelse
-
NCT04216342RekrutteringBetingelser: Kardiovaskulær sygdom
Recent CRA jobs
-
FSP - Patient Recruitment Specialist
-
Associate Clinical Research Associate (FSP)
-
ExecuPharm FSP - Sr. Automation Engineer
-
Initiation Clinical Research Associate II/Senior iCRA (study start-up)
-
Associate Medical Director, ARIDV/ respiratory, home based, Europe
-
Associate Medical Director - Infectology or Respiratory
-
Coordinateur Administratif - Alternance
-
Business Analyst, MDM
-
Business Analyst, Master Data Management
-
Data Team Lead - Real World Evidence (homebased in the United Kingdom)